Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Type of study
Language
Publication year range
1.
Neuroimmunomodulation ; 21(4): 206-12, 2014.
Article in English | MEDLINE | ID: mdl-24504177

ABSTRACT

BACKGROUND: Some premature features of immunosenescence have been associated with persistent viral infections and altered populations of T cells. In particular, the inverted T CD4:CD8 ratio has been correlated with increased morbidity and mortality across different age groups. OBJECTIVE: Here, we investigated the role of persistent viral infections, cognitive and functional states as predictors of inverted CD4:CD8 ratio of older adults in a developing country. METHODS: Three hundred and sixty community-dwelling older adults (aged 60-103 years) were recruited. Cognitive function was evaluated by the Instrument of Brief Neuropsychological Assessment and Mini-Mental State Examination inventory. Functional Activities Questionnaire was used to determine activities of daily living. Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) serologies were determined by ELISAs. Peripheral blood was assessed for lymphocyte subsets by flow cytometry (CD4+, CD8+, NK, NKT, B and CD8+CD28-). RESULTS: Fifty-nine individuals were identified with CD4:CD8 ratio <1, and had increased IgG titers to CMV (p < 0.01), but not to EBV, compared to subjects with CD4:CD8 ratio >1. The older adults with inverted CD4:CD8 ratio had impairments in some cognitive dimensions and had more functional disability and dependency (p = 0.01) than subjects with CD4:CD8 ratio >1. The lymphocyte subsets did not vary between groups. The increased CMV-IgG titers alone contributed to 8× higher chance to invert CD4:CD8 T cell ratio (OR 8.12, 95% CI 1.74-37.88, p < 0.01). CONCLUSION: Our data further indicate the role of CMV on circulating T cells, poor cognition and functional disability/dependency during aging.


Subject(s)
Aging/immunology , CD4-CD8 Ratio , Cognition , Cytomegalovirus Infections/complications , Cytomegalovirus Infections/immunology , Aged , Aged, 80 and over , Female , Flow Cytometry , Humans , Immunophenotyping , Male , Middle Aged , Neuropsychological Tests
2.
Biogerontology ; 14(1): 9-20, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23283592

ABSTRACT

There is evidence suggesting that immunosenescence can be accelerated by external factors such as chronic stress. Here we review potential psychoneuroendocrine determinants of premature aging of the immune system and discuss available interventions aimed at attenuating immunosenescence. Chronic stress may accelerate various features of immunosenescence by activating key allostatic systems, notably the hypothalamic-pituitary-adrenal axis. The immunological impact of such neuroendocrine dysregulation may be further amplified by a dramatic decline in dehydroepiandrosterone (DHEA) levels, acting in part as an endogenous glucocorticoid antagonist. Stress-buffering strategies show beneficial effects on various biomarkers in elderly populations. Likewise, supplementation of DHEA, melatonin or growth hormone has yielded significant beneficial effects in a number of studies, including: increased well-being, memory performance, bone mineral density and improved immunocompetence as evidenced by results of in vitro (T cell proliferation, cytotoxicity, cytokine production), and in vivo immune challenges. However, the side-effects of hormonal supplementation are also discussed. Finally, moderate exercise via the promotion of cortisol/DHEA balance or epigenetic modifications, is associated with lower serum pro-inflammatory cytokines, greater lymphoproliferative responses and lower counts of senescent T cells. Taken together, these data suggest that immune system is plastic and immunosenescence can be attenuated psychoneuroendocrine interventions.


Subject(s)
Aging/immunology , Aging/physiology , Aging/psychology , Aging, Premature/physiopathology , Aging, Premature/psychology , Aging, Premature/therapy , Dehydroepiandrosterone/administration & dosage , Female , Ghrelin/therapeutic use , Human Growth Hormone/therapeutic use , Humans , Male , Melatonin/therapeutic use , Motor Activity , Neuroimmunomodulation/physiology , Neurosecretory Systems/immunology , Neurosecretory Systems/physiology , Social Support , Stress, Physiological/immunology
SELECTION OF CITATIONS
SEARCH DETAIL